covend24
Biologicalexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 9, 2021 (NCT04902183)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04902183 | Phase 2 | Jun 9, 2021 | Athens Medical Society, Elpen Pharmaceutical Co. Inc., OBCTCD24 Ltd, University of Athens |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Athens Medical Society | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Elpen Pharmaceutical Co. Inc. | For profit | 1 | 0 | 1 | 2021 |
| OBCTCD24 Ltd | For profit | 1 | 0 | 1 | 2021 |
| University of Athens | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1